178 related articles for article (PubMed ID: 30419818)
1. Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus.
Jing C; Liu C; Liu F; Gao Y; Liu Y; Guan Z; Xuan B; Yu Y; Yang G
BMC Microbiol; 2018 Nov; 18(1):181. PubMed ID: 30419818
[TBL] [Abstract][Full Text] [Related]
2. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
3. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
[TBL] [Abstract][Full Text] [Related]
4. Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.
Rouha H; Weber S; Janesch P; Maierhofer B; Gross K; Dolezilkova I; Mirkina I; Visram ZC; Malafa S; Stulik L; Badarau A; Nagy E
Virulence; 2018 Jan; 9(1):231-247. PubMed ID: 29099326
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against
Nguyen NTQ; Doan TNM; Sato K; Tkaczyk C; Sellman BR; Diep BA
Front Immunol; 2023; 14():1260627. PubMed ID: 37781371
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice.
Ortines RV; Wang Y; Liu H; Dikeman DA; Pinsker BL; Miller RJ; Kim SE; Ackerman NE; Rizkallah JF; Marcello LT; Cohen TS; Tkaczyk C; Sellman BR; Miller LS
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138566
[TBL] [Abstract][Full Text] [Related]
7. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
8. Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
Vu TTT; Nguyen NTQ; Tran VG; Gras E; Mao Y; Jung DH; Tkaczyk C; Sellman BR; Diep BA
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844012
[No Abstract] [Full Text] [Related]
9. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
[No Abstract] [Full Text] [Related]
10. The prevalence of genes encoding leukocidins in Staphylococcus aureus strains resistant and sensitive to methicillin isolated from burn patients in Taleghani Hospital, Ahvaz, Iran.
Khosravi AD; Hoveizavi H; Farshadzadeh Z
Burns; 2012 Mar; 38(2):247-51. PubMed ID: 21924558
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus Coordinates Leukocidin Expression and Pathogenesis by Sensing Metabolic Fluxes via RpiRc.
Balasubramanian D; Ohneck EA; Chapman J; Weiss A; Kim MK; Reyes-Robles T; Zhong J; Shaw LN; Lun DS; Ueberheide B; Shopsin B; Torres VJ
mBio; 2016 Jun; 7(3):. PubMed ID: 27329753
[TBL] [Abstract][Full Text] [Related]
12. Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins.
Yanai M; Rocha MA; Matolek AZ; Chintalacharuvu A; Taira Y; Chintalacharuvu K; Beenhouwer DO
PLoS One; 2014; 9(2):e89308. PubMed ID: 24586678
[TBL] [Abstract][Full Text] [Related]
13. Antigenic landscapes on
Kailasan S; Kant R; Noonan-Shueh M; Kanipakala T; Liao G; Shulenin S; Leung DW; Alm RA; Adhikari RP; Amarasinghe GK; Gross ML; Aman MJ
MAbs; 2022; 14(1):2083467. PubMed ID: 35730685
[No Abstract] [Full Text] [Related]
14. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
15. Identification of biologic agents to neutralize the bicomponent leukocidins of
Chan R; Buckley PT; O'Malley A; Sause WE; Alonzo F; Lubkin A; Boguslawski KM; Payne A; Fernandez J; Strohl WR; Whitaker B; Lynch AS; Torres VJ
Sci Transl Med; 2019 Jan; 11(475):. PubMed ID: 30651319
[TBL] [Abstract][Full Text] [Related]
16.
Berends ETM; Zheng X; Zwack EE; Ménager MM; Cammer M; Shopsin B; Torres VJ
mBio; 2019 Jan; 10(1):. PubMed ID: 30602580
[No Abstract] [Full Text] [Related]
17. Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.
Thomsen IP; Sapparapu G; James DBA; Cassat JE; Nagarsheth M; Kose N; Putnam N; Boguslawski KM; Jones LS; Wood JB; Creech CB; Torres VJ; Crowe JE
J Infect Dis; 2017 Apr; 215(7):1124-1131. PubMed ID: 28186295
[TBL] [Abstract][Full Text] [Related]
18. Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).
Wood JB; Jones LS; Soper NR; Nagarsheth M; Creech CB; Thomsen IP
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874371
[TBL] [Abstract][Full Text] [Related]
19. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
20. Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia.
Tam K; Lacey KA; Devlin JC; Coffre M; Sommerfield A; Chan R; O'Malley A; Koralov SB; Loke P; Torres VJ
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32602902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
